<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10092783" created="15/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10092783</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T2" lex="IL-2" sem="Protein_molecule">IL-2</term>-mediated <term id="T46" sem="Other"><term id="A1" sem="Other">cell cycle</term> progression</term> and inhibition of <term id="T3" lex="apoptosis" sem="Other">apoptosis</term> does not require <term id="T4" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> or <term id="A2" sem="Protein_complex">activating protein-1</term> activation in <term id="A3" sem="Cell_natural">primary human T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<clue>IL-2-mediated cell cycle <clueType>progression</clueType> and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<clue>IL-2-mediated cell cycle progression and <clueType>inhibition</clueType> <linkTheme>of</linkTheme> apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T2"/>
<clue>IL-2-<clueType>mediated</clueType> cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>IL-2-<clueType>mediated</clueType> cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 <clueType>activation</clueType> in primary human T cells.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 <clueType>activation</clueType> in primary human T cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E7">
<type class="Correlation"/>
<theme idref="E3"/>
<theme idref="E5"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does <cluePolarity>not</cluePolarity> <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E8">
<type class="Correlation"/>
<theme idref="E3"/>
<theme idref="E6"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does <cluePolarity>not</cluePolarity> <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E9">
<type class="Correlation"/>
<theme idref="E4"/>
<theme idref="E5"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does <cluePolarity>not</cluePolarity> <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E10">
<type class="Correlation"/>
<theme idref="E4"/>
<theme idref="E6"/>
<clue>IL-2-mediated cell cycle progression and inhibition of apoptosis does <cluePolarity>not</cluePolarity> <clueType>require</clueType> NF-kappa B or activating protein-1 activation <clueLoc>in primary human T cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T5" lex="IL-2" sem="Protein_molecule">IL-2</term> growth hormone is the major growth factor of activated <term id="T6" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> during a developing <term id="T1" sem="Other">immune response</term>.</sentence>
<sentence id="S3"><term id="T8" lex="IL-2" sem="Protein_molecule">IL-2</term> is required not only for <term id="A4" sem="Other">cell cycle</term> progression but also to protect <term id="T9" lex="Ag-activated_T_cell" sem="Cell_natural">Ag-activated T cells</term> from <term id="T10" lex="programmed_cell_death" sem="Other">programmed cell death</term>.</sentence>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<clue>IL-2 is required not only for cell cycle <clueType>progression</clueType> but also to protect Ag-activated T cells from programmed cell death.</clue>
</event>
<event KT="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="T10"/>
<clue>IL-2 is required not only for cell cycle progression but also to <clueType>protect</clueType> <clueLoc>Ag-activated T cells</clueLoc> <linkTheme>from</linkTheme> programmed cell death.</clue>
</event>
<event KT="Fact" id="E13">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="T8"/>
<clue>IL-2 is <clueType>required</clueType> not only <linkTheme>for</linkTheme> cell cycle progression but also to protect Ag-activated T cells from programmed cell death.</clue>
</event>
<event KT="Fact" id="E14">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T8"/>
<clue>IL-2 is <clueType>required</clueType> not only for cell cycle progression but also <linkTheme>to</linkTheme> protect Ag-activated T cells from programmed cell death.</clue>
</event>
<sentence id="S4">In several cell types, activation of <term id="T11" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> and/or <term id="T12" lex="activating_protein-1" sem="Protein_complex">activating protein-1</term> (<term id="T13" lex="AP-1" sem="Protein_complex">AP-1</term>) has been demonstrated to be extremely important in blocking <term id="T14" lex="apoptosis" sem="Other">apoptosis</term>.</sentence>
<event KT="Other" id="E15">
<type class="Negative_regulation"/>
<theme idref="T14"/>
<clue>In several cell types, activation of NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in <clueType>blocking</clueType> apoptosis.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<clue>In several cell types, <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in blocking apoptosis.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<clue>In several cell types, <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B and/or activating protein-1 (AP-1) has been demonstrated to be extremely important in blocking apoptosis.</clue>
<comment>NER T12,T13 mod</comment></event>
<event KT="Analysis" Source="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E16"/>
<clue><clueLoc>In several cell types</clueLoc>, activation of NF-kappa B and/or activating protein-1 (AP-1) <clueSource>has been</clueSource> <clueKT>demonstrated</clueKT> to <clueType>be</clueType> extremely <clueType>important</clueType> <linkTheme>in</linkTheme> blocking apoptosis.</clue>
</event>
<event KT="Analysis" Source="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="E17"/>
<clue><clueLoc>In several cell types</clueLoc>, activation of NF-kappa B and/or activating protein-1 (AP-1) <clueSource>has been</clueSource> <clueKT>demonstrated</clueKT> to <clueType>be</clueType> extremely <clueType>important</clueType> <linkTheme>in</linkTheme> blocking apoptosis.</clue>
</event>
<sentence id="S5">To determine whether either or both of these <term id="T15" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> are involved in <term id="T16" lex="cell_survival" sem="Other"><term id="A6" sem="Cell_natural">cell</term> survival</term> or <term id="T17" lex="cell_cycle_progression" sem="Other"><term id="A5" sem="Other">cell cycle</term> progression</term> in response to <term id="T18" lex="IL-2" sem="Protein_molecule">IL-2</term>, <term id="T19" lex="primary_human_T_cell" sem="Cell_natural">primary human T cells</term> responsive to the growth factor were analyzed for <cons id="T20" lex="(AND NF-kappa_B_activation AP-1_activation)" sem="(AND Other Other)"><frag id="F1">NF-kappa B</frag> and <frag id="F2">AP-1</frag> <frag id="F3">activation</frag></cons>.</sentence>
<event KT="Other" id="E20">
<type class="Cellular_physiological_process"/>
<theme idref="A6"/>
<clue>To determine whether either or both of these transcription factors are involved in cell <clueType>survival</clueType> or cell cycle progression <linkCause>in response to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Other" id="E50">
<type class="Regulation"/>
<theme idref="E20"/>
<cause idref="T18"/>
<clue>To determine whether either or both of these transcription factors are involved in cell survival or cell cycle progression in <clueType>response</clueType> <linkCause>to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="T18"/>
<clue>To determine whether either or both of these transcription factors are involved in cell survival or cell cycle <clueType>progression</clueType> <linkCause>in response to</linkCause> IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Investigation" id="E22" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E50"/>
<theme idref="T11"/>
<clue><clueKT>To determine</clueKT> whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Investigation" id="E51" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E50"/>
<theme idref="T13"/>
<clue><clueKT>To determine</clueKT> whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Investigation" id="E23" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="T11"/>
<clue><clueKT>To determine</clueKT> whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Investigation" id="E52" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="T13"/>
<clue><clueKT>To determine</clueKT> whether either or both of <corefCause>these transcription factors</corefCause> are <clueType>involved</clueType> <linkTheme>in</linkTheme> cell survival or cell cycle progression in response to IL-2, primary human T cells responsive to the growth factor were analyzed for NF-kappa B and AP-1 activation.</clue>
</event>
<sentence id="S6">The current study clearly demonstrates that <term id="T21" lex="IL-2" sem="Protein_molecule">IL-2</term> does not induce <term id="T22" lex="I_kappa_B_alpha_degradation" sem="Other"><term id="T23" lex="I_kappa_B" sem="Protein_molecule">I kappa B alpha</term> degradation</term> or <term id="T24" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation in <term id="T25" lex="primary_human_T_cell" sem="Cell_natural">primary human T cells</term> that respond to <term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term> by entering the <term id="A7" sem="Other">cell cycle</term> and avoiding <term id="T27" lex="apoptosis" sem="Other">apoptosis</term>.</sentence>
<event KT="Other" id="E24">
<type class="Protein_catabolism"/>
<theme idref="T23"/>
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha <clueType>degradation</clueType> or NF-kappa B activation in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
<comment>NER T23 mod</comment></event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="T24"/>
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B <clueType>activation</clueType> in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E26">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="T21"/>
<clue>The current study clearly <clueKT>demonstrates</clueKT> that IL-2 does <cluePolarity>not</cluePolarity> <clueType>induce</clueType> I kappa B alpha degradation or NF-kappa B activation <clueLoc>in primary human T cells</clueLoc> that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E27">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="T21"/>
<clue>The current study clearly <clueKT>demonstrates</clueKT> that IL-2 does <cluePolarity>not</cluePolarity> <clueType>induce</clueType> I kappa B alpha degradation or NF-kappa B activation <clueLoc>in primary human T cells</clueLoc> that respond to IL-2 by entering the cell cycle and avoiding apoptosis.</clue>
</event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<cause idref="T26"/>
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B activation in <clueLoc>primary human T cells</clueLoc> that <linkCause>respond to</linkCause> IL-2 by <clueType>entering</clueType> the cell cycle and avoiding apoptosis.</clue>
</event>
<event KT="Other" id="E29">
<type class="Negative_regulation"/>
<theme idref="T27"/>
<cause idref="T26"/>
<clue>The current study clearly demonstrates that IL-2 does not induce I kappa B alpha degradation or NF-kappa B activation in <clueLoc>primary human T cells</clueLoc> that <linkCause>respond to</linkCause> IL-2 by entering the cell cycle and <clueType>avoiding</clueType> apoptosis.</clue>
</event>
<sentence id="S7">Similarly, <term id="T28" lex="IL-2" sem="Protein_molecule">IL-2</term> neither activates <term id="T29" lex="JNK" sem="Protein_family_or_group">JNK</term> nor increases <term id="T30" lex="AP-1_binding_activity" sem="Other"><term id="T31" lex="AP-1" sem="Protein_complex">AP-1</term> binding activity</term> to a consensus <term id="T32" lex="o-tetradecanoylphorbol_13-acetate_(TPA)_response_element" sem="DNA_domain_or_region"><term id="T33" lex="o-tetradecanoylphorbol_13-acetate" sem="Organic_compound_other">o-tetradecanoylphorbol 13-acetate</term> (<term id="T34" lex="TPA" sem="Organic_compound_other">TPA</term>) response element</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<cause idref="T28"/>
<clue>Similarly, IL-2 <cluePolarity>neither</cluePolarity> <clueType>activates</clueType> JNK nor increases AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
</event>
<event id="E31">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="T32"/>
<clue>Similarly, IL-2 neither activates JNK nor increases AP-1 <clueType>binding</clueType> activity <linkTheme>to</linkTheme> a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
<comment>NER T31 mod</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T28"/>
<clue>Similarly, IL-2 neither activates JNK <cluePolarity>nor</cluePolarity> <clueType>increases</clueType> AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element.</clue>
</event>
<sentence id="S8">On the other hand, the <term id="T35" lex="growth_factor" sem="Protein_family_or_group">growth factor</term> does induce the activation of <term id="T36" lex="STAT3" sem="Protein_molecule">STAT3</term> and <term id="T37" lex="STAT5" sem="Protein_family_or_group">STAT5</term> in these cells, as has been previously demonstrated.</sentence>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>On the other hand, the growth factor does induce the <clueType>activation</clueType> <linkTheme>of</linkTheme> STAT3 and STAT5 in these cells, as has been previously demonstrated.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>On the other hand, the growth factor does induce the <clueType>activation</clueType> <linkTheme>of</linkTheme> STAT3 and STAT5 in these cells, as has been previously demonstrated.</clue>
</event>
<event id="E35">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<cause idref="T28"/>
<clue>On the other hand, <corefCause>the growth factor</corefCause> does <clueType>induce</clueType> the activation of STAT3 and STAT5 <clueLoc>in these cells</clueLoc>, as has been previously demonstrated.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="T28"/>
<clue>On the other hand, <corefCause>the growth factor</corefCause> does <clueType>induce</clueType> the activation of STAT3 and STAT5 <clueLoc>in these cells</clueLoc>, as has been previously demonstrated.</clue>
</event>
<sentence id="S9">These data show that neither <term id="T39" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> nor <term id="T40" lex="AP-1_activation" sem="Other"><term id="T41" lex="AP-1" sem="Protein_complex">AP-1</term> activation</term> is required for <term id="T43" lex="IL-2" sem="Protein_molecule">IL-2</term>-mediated <term id="A9" sem="Other">survival</term> or <term id="T44" lex="cell_cycle_progression" sem="Other"><term id="A8" sem="Other">cell cycle</term> progression</term> in activated <term id="T45" lex="primary_human_T_cell" sem="Cell_natural">primary human T cells</term>.</sentence>
<event KT="Other" id="E37">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="T43"/>
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-<clueType>mediated</clueType> survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-mediated survival or cell cycle <clueType>progression</clueType> in activated primary human T cells.</clue>
</event>
<event KT="Other" id="E39">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="T43"/>
<clue>These data show that neither NF-kappa B nor AP-1 activation is required for IL-2-<clueType>mediated</clueType> survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event KT="Other" id="E40">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>These data show that neither NF-kappa B nor AP-1 <clueType>activation</clueType> is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event KT="Other" id="E41">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<clue>These data show that neither NF-kappa B nor AP-1 <clueType>activation</clueType> is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E42">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E40"/>
<clue>These data <clueKT>show</clueKT> that <cluePolarity>neither</cluePolarity> NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E43">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="E40"/>
<clue>These data <clueKT>show</clueKT> that <cluePolarity>neither</cluePolarity> NF-kappa B nor AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E44">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="E41"/>
<clue>These data <clueKT>show</clueKT> that neither NF-kappa B <cluePolarity>nor</cluePolarity> AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E45">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="E41"/>
<clue>These data <clueKT>show</clueKT> that neither NF-kappa B <cluePolarity>nor</cluePolarity> AP-1 activation is <clueType>required</clueType> <linkTheme>for</linkTheme> IL-2-mediated survival or cell cycle progression <clueLoc>in activated primary human T cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
